The recent rise for Catalent can be attributed to reports of Danaher looking to acquire the company. Catalent’s revenue growth over the recent years was primarily driven by robust demand for its ...

So I found the recent news that Danaher is interested in acquiring contract manufacturer Catalent, Inc. (CTLT) quite interesting. Putting myself in the shoes of an investor who plans to buy shares ...

SEE RELATED STORY: 'Ultimately, this intervention is necessary': State announces official TEA takeover of Houston ISD But before anything becomes official, there are plenty of questions left for ...

Houston is the largest school district in Texas and the eighth largest in the U.S. While the state of Texas claims the planned takeover is about school improvement, my research on state takeovers ...

We’ll send you a myFT Daily Digest email rounding up the latest Credit Suisse Group AG news every morning. BlackRock drew up a rival bid for Credit Suisse that would trump a plan blessed by the ...

Life sciences and medical diagnostics company Danaher (DHR) reported better-than-expected earnings and revenue for the fourth quarter. We view the dip in the stock as unjustified and an opportunity.

Catalent, Inc. CTLT recently announced its successful formulation design and clinical-phase manufacturing collaboration with Grünenthal for an orally dosed small molecule in the latter’s pipeline.

Switzerland’s largest bank, UBS, is reportedly approaching a deal to take over its troubled rival Credit Suisse, a move that could ease growing concerns that the turbulence at the European ...

Danaher (NYSE:DHR) has had a rough three months with its share price down 7.3%. However, stock prices are usually driven by a company’s financial performance over the long term, which in this ...

UKRAINE - 2021/05/04: In this Photo illustration a Catalent logo of a pharmaceutical company is seen ... [+] on a smartphone and a pc screen. (Photo Illustration by Pavlo Gonchar/SOPA Images ...